Clinical and Experimental Medicine

Laboratories 2024/2025 - Experimental and Clinical Medicine

Please find below the list of the Supervisors (with a link to their CV) and their PhD Projects proposed for the academic year 2024/2025 for the curriculum in Experimental and Clinical Medicine.

The list includes the project based fellowships and below the free projects among which the candidates, who passed the first evaluation phase, must express their preference as indicated in the Call for Applications.

6 PROJECTS-BASED FELLOWSHIP:

Project-Based Fellowship ECM2: SOLLINI MARTA

Unit: Nuclear Medicine Unit– IRCCS Ospedale San Raffaele

ECM2: Advanced Imaging Techniques in FAPI PET/CT to Stage and Predict the Outcome of Bladder Cancer

Project-Based Fellowship ECM3: CHITI ARTURO

Unit: Nuclear Medicine Unit– IRCCS Ospedale San Raffaele

Funded in the context of EU funds – NextGeneration EU- pursuant to DM 630/2024

ECM3: Development of Molecular Imaging Biomarkers for Solid Tumors

Project-Based Fellowship ECM4: ANASTASIA LUIGI

Unit: IRCCS Ospedale San Raffaele e Istitute of Molecular and Translational Cardiology Policlinico San Donato

Funded in the context of EU funds – NextGeneration EU- pursuant to DM 630/2024

ECM4: Exploring Protein Sialylation in Brugada Syndrome: Implications for Clinical Management and Diagnosis

Project-Based Fellowship ECM5: ARCIDIACONO PAOLO GIORGIO

Unit: Pancreatico/Biliary Endoscopy & Endosonography Unit– IRCCS Ospedale San Raffaele

Funded in the context of EU funds – NextGeneration EU- pursuant to DM 630/2024

ECM5: The application of deep learning tools at EUS to predict diagnosis, prognosis and molecular alterations in pancreatic cancer

Project-Based Fellowship ECM6: ALFANO MASSIMO

Unit: Extracellular Microenvironment Unit – IRCCS Ospedale San Raffaele

Funded in the context of EU funds – NextGeneration EU- pursuant to DM 630/2024

ECM6: The predictive role of the microbiome in BGC response in patients with high-grade bladder cancer

CHITI ARTURO

Unit: Nuclear Medicine

Quantitative PET/MR in oncology